Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era.
O'Reilly S, Lynch E, Hwang ES, Brown M, O'Donovan T, Hennessy MA, McGinty G, Barry A, Weadick CS, van Leeuwen R, van de Poll M, Curigliano G, O'Sullivan MJ, Thomas A. O'Reilly S, et al. Among authors: van de poll m, van leeuwen r. Clin Breast Cancer. 2025 Apr;25(3):198-213. doi: 10.1016/j.clbc.2024.11.010. Epub 2024 Nov 21. Clin Breast Cancer. 2025. PMID: 39668009 Free article. Review.
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
Braal CL, Hussaarts KGAM, Seuren L, Oomen-de Hoop E, de Bruijn P, Buck SAJ, Bos MEMM, Thijs-Visser MF, Zuetenhorst HJM, Mathijssen-van Stein D, Vastbinder MB, van Leeuwen RWF, van Gelder T, Koolen SLW, Jager A, Mathijssen RHJ. Braal CL, et al. Breast Cancer Res Treat. 2020 Nov;184(1):107-113. doi: 10.1007/s10549-020-05829-6. Epub 2020 Aug 16. Breast Cancer Res Treat. 2020. PMID: 32803636 Free PMC article. Clinical Trial.
Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
Braal CL, Hussaarts KGAM, Seuren L, Oomen-deHoop E, de Bruijn P, Buck SAJ, Bos MEMM, Thijs-Visser MF, Zuetenhorst HJM, Mathijssen-van Stein D, Vastbinder MB, van Leeuwen RWF, van Gelder T, Koolen SLW, Jager A, Mathijssen RHJ. Braal CL, et al. Breast Cancer Res Treat. 2021 Feb;185(3):889. doi: 10.1007/s10549-020-05979-7. Breast Cancer Res Treat. 2021. PMID: 33226493 Free PMC article. No abstract available.
The added value of H2 antagonists in premedication regimens during paclitaxel treatment.
Cox JM, van Doorn L, Malmberg R, Oomen-de Hoop E, Bosch TM, van den Bemt PMLA, Boere IA, Jager A, Mathijssen RHJ, van Leeuwen RWF. Cox JM, et al. Among authors: van leeuwen rwf, van doorn l, van den bemt pmla. Br J Cancer. 2021 May;124(10):1647-1652. doi: 10.1038/s41416-021-01313-0. Epub 2021 Mar 24. Br J Cancer. 2021. PMID: 33762718 Free PMC article. Clinical Trial.
Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives.
Malmberg R, Agema BC, Hofman MM, Oosterveld S, Bins S, Dumoulin DW, Joosse A, Aerts JGJV, Debets R, Koch BCP, van der Veldt AAM, van Leeuwen RWF, Mathijssen RHJ. Malmberg R, et al. Among authors: van leeuwen rwf, van der veldt aam. Cancer Commun (Lond). 2025 Apr;45(4):471-475. doi: 10.1002/cac2.12661. Epub 2025 Jan 16. Cancer Commun (Lond). 2025. PMID: 39817458 Free PMC article. No abstract available.
Drug-drug interactions in pediatric oncology patients.
Balk TE, van der Sijs IH, van Gelder T, Janssen JJB, van der Sluis IM, van Leeuwen RWF, Engels FK. Balk TE, et al. Among authors: van leeuwen rwf, van der sluis im, van der sijs ih, van gelder t. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26410. Epub 2017 Feb 16. Pediatr Blood Cancer. 2017. PMID: 28205376
401 results